Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Metoclopramide 10mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cancer
1 trial -
Midazolam 0.03mg/kg
Hospital Authority, Hong Kong
Child
1 trial -
Midazolam premedication
Hospital Authority, Hong Kong
Midazolam Premedication
1 trial -
Mindfulness meditation based on brain-computer interface
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Minocycline
The First People's Hospital of Lianyungang
Intracerebral Hemorrhage
1 trial -
Misoprostol
Children's Hospital of Fudan University
Postpartum Hemorrhage
1 trial -
Misoprostol 25 µg Vaginal
ANI PHARMACEUTICALS INC
Cervical Ripening
1 trial -
Mitoquinone mesylate (MitoQ)
United Therapeutics Europe Ltd
Cold Exposure
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Mitoxantrone hydrochloride liposome injection30mg/m2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial -
Miyarisan-BM (Clostridium Butyricum Miyairi)
Hospital Authority, Hong Kong
Clostridium Butyricum Miyairi
1 trial -
Modafinil Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Mononuclear cells
Shandong Provincial Hospital
Chronic Atrophic Gastritis
1 trial -
Morphine
BRIGHT MINDS BIOSCIENCES INC.
Sleep Deprivation
1 trial -
Multi-component Interventions
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
Multi-component intervention package
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
Multiple-dose of Ciprofloxacin prophylaxis
The First People's Hospital of Lianyungang
Kidney Stones
1 trial -
Multistrain Probiotic
Ultragenyx UK Limited
Cystic Fibrosis in Children
1 trial -
Multivitamins
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Mupirocin
Hospital Authority, Hong Kong
Peritoneal Dialysis-related Infection
1 trial -
Mupirocin (drug)
Hospital Authority, Hong Kong
Biopsy Wound
1 trial -
N-butyl-2-cyanoacrylate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Varices
1 trial -
NBP Softgel Capsules
The First People's Hospital of Lianyungang
Migraine
1 trial -
NO Ultra
Atrium Therapeutics
Hypertension
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources